132 related articles for article (PubMed ID: 20229258)
21. Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Hyder SM
Endocr Relat Cancer; 2006 Sep; 13(3):667-87. PubMed ID: 16954424
[TBL] [Abstract][Full Text] [Related]
22. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
24. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
25. Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo.
Dabrosin C
Clin Cancer Res; 2005 Nov; 11(22):8036-41. PubMed ID: 16299233
[TBL] [Abstract][Full Text] [Related]
26. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
27. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
[TBL] [Abstract][Full Text] [Related]
29. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
[TBL] [Abstract][Full Text] [Related]
30. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
Polterauer S; Grimm C; Mustea A; Concin N; Tanner B; Thiel F; Heinze G; Reinthaller A; Zeillinger R; Hefler LA
Gynecol Oncol; 2007 May; 105(2):385-9. PubMed ID: 17289129
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
Garvin S; Dabrosin C
Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
[TBL] [Abstract][Full Text] [Related]
33. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
34. [Gynecologic cancer].
Sugiyama T; Takeuchi S; Fukagawa T
Gan To Kagaku Ryoho; 2014 Feb; 41(2):157-61. PubMed ID: 24743194
[TBL] [Abstract][Full Text] [Related]
35. The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancer.
Landt S; Heidecke H; Reuter C; Korlach S; Blohmer JU; Lichtenegger W; Heusner T; Stöblen F; Thill M; Barinoff J; Sehouli J; Kümmel S
Anticancer Res; 2011 Aug; 31(8):2645-9. PubMed ID: 21778317
[TBL] [Abstract][Full Text] [Related]
36. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
DNA Cell Biol; 2007 Jul; 26(7):453-63. PubMed ID: 17630849
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis Markers in Gynecological Tumors and Patents for Anti-Angiogenic Approach: Review.
Abdalla DR; Simoens C; Bogers JP; Murta EF; Michelin MA
Recent Pat Anticancer Drug Discov; 2015; 10(3):298-307. PubMed ID: 26381660
[TBL] [Abstract][Full Text] [Related]
38. Tumors: wounds that do not heal-redux.
Dvorak HF
Cancer Immunol Res; 2015 Jan; 3(1):1-11. PubMed ID: 25568067
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy poses tough questions for cancer treatment.
Waalen J
J Natl Cancer Inst; 1991 Jul; 83(13):900-2. PubMed ID: 2067030
[No Abstract] [Full Text] [Related]
40. Neoangiogenesis in cervical cancer: focus on CD34 assessment.
Ancuţa C; Ancuţa E; Zugun-Eloae F; Carasevici E
Rom J Morphol Embryol; 2010; 51(2):289-94. PubMed ID: 20495745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
